Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Breast (Edinburgh, Scotland)|January 8, 2022
Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 updateLauren C Brown, Sherene Loi
Patient Education and Counseling|July 13, 2010
Jeopardy!: an innovative approach to teach psychosocial aspects of pediatricsThanakorn Jirasevijinda, Lauren C Brown
Diabetes Research and Clinical Practice|August 24, 2007
Type of antidepressant therapy and risk of type 2 diabetes in people with depressionLauren C Brown, Sumit R Majumdar, Jeffrey A Johnson
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|May 24, 2011
Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysisJm Gamble, Scot H Simpson, Lauren C Brown, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 5, 2006
Type 2 diabetes does not increase risk of depressionLauren C Brown, Sumit R Majumdar, Stephen C Newman, et al.
Diabetes Care|April 28, 2005
History of depression increases risk of type 2 diabetes in younger adultsLauren C Brown, Sumit R Majumdar, Stephen C Newman, et al.
Cancer Journal (Sudbury, Mass.)|January 21, 2021
Tumor-Infiltrating Lymphocyctes in Triple-Negative Breast Cancer: Update for 2020Lauren C Brown, Roberto Salgado, Stephen J Luen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 10, 2004
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosisLauren C Brown, Jeffrey A Johnson, Sumit R Majumdar, et al.
Cancer|May 7, 2020
Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine functionLauren C Brown, Amy R Murphy, Chloe S Lalonde, et al.
Breast (Edinburgh, Scotland)|October 1, 2025
Baseline tumour burden and prognosis in breast cancer treated with immune checkpoint inhibitorsJulia Dixon-Douglas, Lauren C Brown, Kate Moodie, et al.
Pageof 2